Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation - CodeBreaK 301 - AmgenSee more
Intestinal Microbiome Modulation With Antibiotics in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer - Metronidazole - Conselho Nacional de Desenvolvimento Científico e Tecnólogico - CNPQSee more
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer - OrigAMI-2 - Janssen Research & Development, LLCSee more
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy - OrigAMI-3 - Janssen Research & Development, LLCSee more
Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery - POSBIO-CRC - AC Camargo Cancer CenterSee more
Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy - GLOX-PEN - AC Camargo Cancer CenterSee more
Breast Cancer
Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer - HER2Cell - AC Camargo Cancer CenterSee more
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) - PRESERVE - Sunnybrook Health Sciences CentreSee more
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence - ELEGANT - Stemline Therapeutics, Inc.See more
Lung cancer
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer - PALOMA-2 - Janssen Research & Development, LLCSee more
A Phase 2 Study of AMG 193 in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201) - AmgenSee more
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC - ALKAZAR - Nuvalent Inc.See more
Carcinoid Syndrome
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.See more
Carcinoid tumor
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.See more
Cervical cancer
Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer - Nivolumab - Hospital Israelita Albert EinsteinSee more
Chondrosarcoma
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen - CHONQUER - Servier Bio-Innovation LLCSee more
Gastrointestinal Cancer
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.See more
Head and neck cancer
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone - Boehringer IngelheimSee more
Liver cancer
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.See more
Multiple myeloma
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4 - Janssen PharmaceuticaSee more
Neuroendocrine tumor
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors - EVENET - AC Camargo Cancer CenterSee more
Neuroendocrine Tumor
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors - EVENET - AC Camargo Cancer CenterSee more
Ovarian cancer
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention - TUBA-WISP-II - University Medical Center NijmegenSee more
Pancreatic cancer
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen - CAREFNDR - Crinetics Pharmaceuticals Inc.See more
Peripheral neuropathy
Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy - GLOX-PEN - AC Camargo Cancer CenterSee more
Solid tumors
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer - PALOMA-2 - Janssen Research & Development, LLCSee more